Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
428.6 USD | -0.31% | +4.47% | +5.33% |
May. 14 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.67% | 21.25B | |
-5.99% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B | |
+289.58% | 7.99B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals Insider Sold Shares Worth $577,410, According to a Recent SEC Filing